Menu

依普利酮在国内买的到吗?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

Can I buy it in China? Eplerenone is one of the most effective drugs for the treatment of hypertension. Its English name is Inspra. It was first approved for marketing in the United States in 2002. So far, eplerenone has not been launched in my country and is temporarily unavailable in China.

It is understood that the original drug of eplerenone (Inspra) is available in two specifications in the United States, and the prices are relatively high, 25mg-30 tablets/box, priced at approximately 118.71/USD; 50mg-30 tablets/box, priced at approximately 124.09/USD. Many patients say that the price of original drugs makes them unaffordable when taking them for a long time.

More and more domestic patients are choosing to buy the Indian version of eplerenone, which is a generic drug produced by India's Lupine Pharmaceuticals. The therapeutic effect is basically the same as the original drug, but the price is relatively low. The Indian version of eplerenone (Inspra) is available in 50mg*100 tablets and costs around $500.

There are two common ways for patients to buy eplerenone. One is to go abroad to buy it in person. You don’t have to worry about buying counterfeit drugs in regular pharmacies without going through other people’s hands. The second is to purchase it through a domestic professional overseas medical consulting service company (such as Medical Companion Travel) and through formal channels to ensure that you can buy genuine eplerenone.

The Indian version (Inspra) is taken in the same way as the original drug. It can be used as a single drug or in combination to treat adult patients with hypertension. Initial dose: 50 mg, orally, once a day; Maintenance dose: 50 mg, orally, 1-2 times a day; Maximum dose: 100 mg/day. Obvious antihypertensive effects appear within four weeks of taking the drug. Patients whose blood pressure responds inadequately to the initial dose may be increased to 50 mg twice daily.

Recommended related hot articles: /newsDetail/72977.html

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。